A personalized approach to the surgical treatment of early-stage uterine body cancer with tumor involvement in the lower uterine segment. Clinical observation

Borislav E. Tkachenko , Liana S. Mkrtchyan , Natalya V. Levickaya , Tatev A. Agababyan , Elizaveta V. Sheberova , Darya A. Ushakova , Vladimir A. Petrov , Sergey A. Ivanov , Andrey D. Kaprin

For citation:

Abstract

In the Russian Federation, the incidence of uterine body cancer remains the highest among malignant neoplasms of the female genital organs. Surgical treatment is the primary method for treating early stages of the disease; however, the issue of predicting metastatic lymph node involvement at the preoperative stage for performing lymphadenectomy remains debatable. The potential prognostic significance of tumor involvement in the lower uterine segment regarding lymph node metastases may justify the need to assess tumor localization before starting treatment. Magnetic resonance imaging (MRI) of the pelvic organs can help determine the involvement of the lower uterine segment in the tumor process, thereby creating a basis for expanding the scope of surgical intervention.

Keywords: uterine body cancer, endometrioid adenocarcinoma, lower uterine segment, risk factor, magnetic resonance imaging, sentinel lymph node, indocyanine green.

References

1. Злокачественные новообразования в России в 2022 году (заболеваемость и смертность). Под ред. А.Д. Каприна и др. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2023. Malignant neoplasms in Russia in 2022 (morbidity and mortality). Ed. A.D. Kaprin et al. Moscow: Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre, 2023 (in Russian).

2. Состояние онкологической помощи населению России в 2021 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. The state of cancer care for the Russian population in 2021. Ed.

A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre, 2022 (in Russian).

3. Рак тела матки и саркомы матки: клинические рекомендации. М.: Минздрав России, 2022. [Электронный ресурс] URL: https://cr.minzdrav.gov.ru/recomend/460_3 (Дата обращения 10.04.24). Uterine body cancer and uterine sarcoma: clinical recommendations. Moscow: Ministry of Health of Russia, 2022. [Electronic Resource] URL: https://cr.minzdrav.gov.ru/recomend/460_3 (Accessed 04/10/24) (in Russian).

4. Abu-Rustum N, Yashar C, Arend R et al. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2023;2:181-209. DOI: 10.6004/jnccn.2023.0006

5. Oaknin A, Bosse TJ, Creutzberg CL et al.; ESMO Guidelines Committee. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of oncology. 2022;9:860-77. DOI: 10.1016/j.annonc.2022.05.009

6. Lavie O, Uriev L, Gdalevich M et al. The outcome of patients with stage I endometrial cancer involving the lower uterine segment. Int J Gynecol Cancer. 2008;18:1079-83. DOI: 10.1111/j.1525-1438.2007.01150.x

7. Erkaya S, Öz M, Topçu HO et al. Is lower uterine segment involvement a prognostic factor in endometrial cancer? Turk J Med Sci. 2017;47:300-6. DOI: 10.3906/sag-1602-137

8. Davidesko S, Meirovitz M, Shaco-Levy R et al. The significance of lower uterine segment involvement in endometrial cancer. European Journal of Surgical Oncology. 2024;50:108007. DOI: 10.1016/j.ejso.2024.108007

9. Doll KM, Tseng J, Denslow SA et al. High-grade endometrial cancer: Revisiting the impact of tumor size and location on outcomes. Gynecologic Oncology. 2014;132:44-9. DOI: 10.1016/j.ygyno.2013.10.023

10. Kong TW, Kim J, Kim J et al. A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients. J Gynecol Oncol. 2024. Jan 22. DOI: 10.3802/jgo.2024.35.e53

11. Miyoshi A, Kanao S, Naoi H et al. Investigation of the clinical features of lower uterine segment carcinoma: association with advanced stage disease and indication of poorer prognosis. Arch Gynecol Obstet. 2018;297:193-8. DOI: 10.1007/s00404-017-4576-

12. Jiao S, Wei L, Zou L et al. Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy. J Gynecol Oncol. 2024. Apr 9. DOI: 10.3802/jgo.2024.35.e84

13. Kang S, Lee JM, Lee JK et al. How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study. J Gynecol Oncol. 2012;23(4):251-6. DOI: 10.3802/jgo.2012.23.4.251

14. Frost JA, Webster KE, Bryant A, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. 2015;2015(9):CD007585. DOI: 10.1002/14651858.CD007585.pub3. Update in: Cochrane Database Syst Rev. 2017 Oct 02;10:CD007585. DOI: 10.1002/14651858.CD007585.pub4

15. Holloway RW, Abu-Rustum NR, Backes FJ et al. Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. Gynecol Oncol. 2017;146(2):405-15. DOI: 10.1016/j.ygyno.2017.05.027

16. Sozzi G, Fanfani F, Berretta R et al. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study – a multicentric analysis of predictors of failed mapping. Int J Gynecol Cancer. 2020;30(11):1713-18. DOI: 10.1136/ijgc-2020-001724

17. Meissnitzer M, Forstner R. MRI of endometrium cancer – how we do it. Cancer Imaging. 2016;16:11. DOI: 10.1186/s40644-016-0069-1

18. Gui B, Lupinelli M, Russo L et al. MRI in uterine cancers with uncertain origin: Endometrial or cervical? Radiological point of view with review of the literature. Eur J Radiol. 2022 Aug;153:110357. DOI: 10.1016/j.ejrad.2022.110357

19. Берген Т.А., Фокин В.А., Труфанов Г.Е. Систематизация протокола магнитно-резонансной томографии у женщин с первично-выявленными злокачественными новообразованиями органов таза. Лучевая диагностика и терапия. 2019;(4):41-8. DOI: 10.22328/2079-5343-2019-10-4-41-48 Bergen T.A., Fokin V.A., Trufanov G.E. Systematization of the magnetic resonance imaging protocol in women with primary identified malignant neoplasms of the pelvic organs. Radiation diagnostics and therapy. 2019;(4):41-8. DOI: 10.22328/2079-5343-2019-10-4-41-48 (in Russian).

20. Woo S, Atun R, Ward ZJ et al. Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis. Eur Radiol. 2020;30(10):5560-77. DOI: 10.1007/s00330-020-06909-3

21. Otero-García MM, Mesa-Álvarez A, Nikolic O et al. Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers. Insights Imaging. 2019;10(1):19. DOI: 10.1186/s13244-019-0696-8

22. Olthof EP, Bergink-Voorthuis BJ, Wenzel HHB et al. Diagnostic accuracy of MRI, CT, and [18F]FDG-PET-CT in detecting lymph node metastases in clinically early-stage cervical cancer – a nationwide Dutch cohort study. Insights Imaging. 2024;15(1):36. DOI: 10.1186/s13244-023-01589-1

For citation:Tkachenko B.E., Mkrtchyan L.S., Levickaya N.V., Agababyan T.A., Sheberova E.V., Ushakova D.A., Petrov V.A., Ivanov S.A., Kaprin A.D. A personalized approach to the surgical treatment of early-stage uterine body cancer with tumor involvement in the lower uterine segment. Clinical observation. Clinical review for general practice. 2024; 5 (7): 69–73. (In Russ.). DOI: 10.47407/kr2024.5.7.00449

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Clinical review for general practice